We are live on ! Find out more
LP

LMR Partners Portfolio holdings

AUM $45.4B
1-Year Est. Return 60.68%
This Fund
S&P 500
This Quarter Est. Return
+6.74%
1 Year Est. Return
+60.68%
3 Year Est. Return
+183.94%
5 Year Est. Return
+215.13%
10 Year Est. Return
+663.15%
AUM
$1.26B
AUM Growth
+$52.8M
Cap. Flow
-$28.2M
Cap. Flow %
-2.25%
Top 10 Hldgs %
26.72%
Holding
592
New
139
Increased
37
Reduced
140
Closed
271

Top Buys

Rank Stock Value
1
ORCL icon
Oracle
ORCL
+$57M
2
DD icon
DuPont de Nemours
DD
+$27.3M
3
WMB icon
Williams Companies
WMB
+$23.2M
4
WBD icon
Warner Bros
WBD
+$22.8M
5
HBI
Hanesbrands
HBI
+$22.4M

Sector Composition

Rank Sector Weight
1 Technology 19.12%
2 Healthcare 17.35%
3 Consumer Discretionary 12.13%
4 Financials 10.89%
5 Industrials 10.29%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ARQL
301
DELISTED
Arqule Inc
ARQL
$31K ﹤0.01%
27,670
-100,769
-78% -$133K
FRTX
302
DELISTED
Fresh Tracks Therapeutics, Inc. Common Stock
FRTX
$25K ﹤0.01%
7
-45
-87% -$175K
GMO
303
DELISTED
General Moly, Inc.
GMO
$25K ﹤0.01%
34,605
-89,374
-72% -$87.4K
MDW
304
DELISTED
MIDWAY GOLD CORP (CANADA)
MDW
$25K ﹤0.01%
24,289
-218,602
-90% -$205K
AVNW icon
305
Aviat Networks
AVNW
$262M
$24K ﹤0.01%
2,209
-19,885
-90% -$170K
SPRT
306
DELISTED
support.com, Inc.
SPRT
$24K ﹤0.01%
3,808
-34,270
-90% -$248K
ANAD
307
DELISTED
ANADIGICS INC
ANAD
$24K ﹤0.01%
35,828
-142,294
-80% -$104K
TWER
308
DELISTED
Towerstream Corporation Common Stock
TWER
$23K ﹤0.01%
774
-6,412
-89% -$214K
FBIO icon
309
Fortress Biotech
FBIO
$111M
$22K ﹤0.01%
692
-6,229
-90% -$165K
UEC icon
310
Uranium Energy
UEC
$4.71B
$20K ﹤0.01%
16,661
-149,947
-90% -$226K
DVR
311
DELISTED
CAL DIVE INTERNATIONAL INC COM
DVR
$20K ﹤0.01%
21,197
-190,771
-90% -$190K
OMEX icon
312
Odyssey Marine Exploration
OMEX
$40.4M
$18K ﹤0.01%
1,661
-13,113
-89% -$191K
RSH
313
DELISTED
RADIOSHACK CORP
RSH
$17K ﹤0.01%
16,948
-146,011
-90% -$125K
APP
314
DELISTED
AMERICAN APPAREL INC COM
APP
$16K ﹤0.01%
20,183
-181,650
-90% -$171K
AVEO
315
DELISTED
AVEO Pharmaceuticals, Inc.
AVEO
$13K ﹤0.01%
1,123
-10,108
-90% -$128K
ENZN
316
DELISTED
ENZON PHARMACEUTICALS INC
ENZN
$13K ﹤0.01%
11,250
-101,251
-90% -$125K
WTSL
317
DELISTED
WET SEAL INC CL-A
WTSL
$11K ﹤0.01%
20,626
-185,637
-90% -$155K
RCPI
318
DELISTED
ROCK CREEK PHARMACEUTICALS INC COM STK (DE)
RCPI
$10K ﹤0.01%
1,373
-14,950
-92% -$148K
NSPH
319
DELISTED
NANOSPHERE INC. COM NEW
NSPH
$6K ﹤0.01%
591
-5,316
-90% -$111K
COCO
320
DELISTED
CORINTHIAN COLLEGES INC
COCO
$1K ﹤0.01%
17,157
-154,411
-90% -$27.6K
ABR icon
321
Arbor Realty Trust
ABR
$960M
-54,084
Closed -$376K
ABT icon
322
Abbott
ABT
$180B
-208,814
Closed -$8.54M
ACHV icon
323
Achieve Life Sciences
ACHV
$626M
-14
Closed -$119K
ADBE icon
324
Adobe
ADBE
$89.5B
-51,576
Closed -$3.73M
ADSK icon
325
Autodesk
ADSK
$44.3B
-47,831
Closed -$2.7M

Similar funds

LMR Partners's Q3 2014 Portfolio in Review

As of Q3 2014, LMR Partners held 592 positions worth $1.26B, up 4.4% from $1.2B the previous quarter. Its ten largest holdings account for 27% of the portfolio.

LMR Partners's Q3 2014 filing shows 139 new, 37 increased, 140 reduced and 271 closed positions. Its largest new stake was Oracle: 1,407,012 shares worth $53.9M. The largest sale was iShares MSCI Emerging Markets ETF, an estimated $45.7M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 9.3% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • LMR Partners's largest Q3 2014 buy was Oracle: 1,407,012 shares worth $53.9M.
  • LMR Partners added most to DuPont de Nemours in Q3 2014, an estimated $27.3M increase.
  • LMR Partners's biggest Q3 2014 reduction was Liberty Global Class A, cutting an estimated $29.8M.
  • LMR Partners fully exited iShares MSCI Emerging Markets ETF in Q3 2014, selling an estimated $45.7M.
  • LMR Partners's ten largest holdings make up 27% of its $1.26B portfolio in Q3 2014.
  • LMR Partners opened 139 new positions and closed 271 in Q3 2014.
  • LMR Partners's portfolio value rose 4.4% quarter-over-quarter to $1.26B.

Based on LMR Partners's 13F filing for Q3 2014, filed 20 Oct 2014.